Mannino, F.; Urzì Brancati, V.; Lauro, R.; Pirrotta, I.; Rottura, M.; Irrera, N.; Cavallini, G.M.; Pallio, G.; Gitto, E.; Manti, S.
Levosimendan and Dobutamin Attenuate LPS-Induced Inflammation in Microglia by Inhibiting the NF-κB Pathway and NLRP3 Inflammasome Activation via Nrf2/HO-1 Signalling. Biomedicines 2024, 12, 1009.
https://doi.org/10.3390/biomedicines12051009
AMA Style
Mannino F, Urzì Brancati V, Lauro R, Pirrotta I, Rottura M, Irrera N, Cavallini GM, Pallio G, Gitto E, Manti S.
Levosimendan and Dobutamin Attenuate LPS-Induced Inflammation in Microglia by Inhibiting the NF-κB Pathway and NLRP3 Inflammasome Activation via Nrf2/HO-1 Signalling. Biomedicines. 2024; 12(5):1009.
https://doi.org/10.3390/biomedicines12051009
Chicago/Turabian Style
Mannino, Federica, Valentina Urzì Brancati, Rita Lauro, Igor Pirrotta, Michelangelo Rottura, Natasha Irrera, Gian Maria Cavallini, Giovanni Pallio, Eloisa Gitto, and Sara Manti.
2024. "Levosimendan and Dobutamin Attenuate LPS-Induced Inflammation in Microglia by Inhibiting the NF-κB Pathway and NLRP3 Inflammasome Activation via Nrf2/HO-1 Signalling" Biomedicines 12, no. 5: 1009.
https://doi.org/10.3390/biomedicines12051009
APA Style
Mannino, F., Urzì Brancati, V., Lauro, R., Pirrotta, I., Rottura, M., Irrera, N., Cavallini, G. M., Pallio, G., Gitto, E., & Manti, S.
(2024). Levosimendan and Dobutamin Attenuate LPS-Induced Inflammation in Microglia by Inhibiting the NF-κB Pathway and NLRP3 Inflammasome Activation via Nrf2/HO-1 Signalling. Biomedicines, 12(5), 1009.
https://doi.org/10.3390/biomedicines12051009